Individuals with potential exposure to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
do not necessarily develop PCR or antibody positivity, suggesting that some …

While type I interferons (IFNs) are universally acknowledged for their antiviral and immunostimulatory
functions, there is increasing appreciation of the detrimental effects of inappropriate…

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine rollout has coincided
with the spread of variants of concern. We investigated whether single-dose vaccination, …

… Mala K. Maini filed a patent for TRAIL blocking in viral hepatitis, received an unrestricted
educational grant from BMS and sat on advisory boards for Roche, Transgene, ITS. Dimitra …

Understanding the nature of immunity following mild/asymptomatic infection with SARS-CoV-2
is crucial to controlling the pandemic. We analyzed T cell and neutralizing antibody …

Liver cancer, more specifically hepatocellular carcinoma (HCC), is the second leading cause
of cancer-related death and its incidence is increasing globally. Around 50% of patients …

Hepatitis B virus (HBV) is a noncytopathic virus, and the recognition of infected hepatocytes
by HBV-specific CD8 cells has been assumed to be the central mechanism causing both …

The Omicron, or Pango lineage B.1.1.529, variant of severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) carries multiple spike mutations with high transmissibility and …

The liver has vital metabolic and clearance functions that involve the uptake of nutrients,
waste products and pathogens from the blood. In addition, its unique immunoregulatory …

After hepatitis B virus (HBV) infection, liver injury and viral control have been thought to result
from lysis of infected hepatocytes by virus-specific cytotoxic T cells. Patients are usually …